GI Dynamics’ indigestion problems

The company, which sells intestinal liners, has lost nearly half of its market weight this year.

What’s eating GI Dynamics (GID)? The stock has lost nearly half its market value since the start of the calendar year and there seems to be little appetite from investors, despite its record low share price and huge earnings potential.

The $160 million market cap junior is trying to commercialise its intestinal liner to help fight obesity and diabetes – a global market that is measured not in the hundreds of millions but billions of dollars.


{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device

Register as a new member

(using a different email)

Related Articles